Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Brambilla (Grenoble, France). The role of the EGFR-pathway and angiogenesis in lung cancer: basic considerations. Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies

Member's Comments

No comment yet.

Related content which might interest you: The biology of lung cancer Source: Eur Respir Mon; 2009: 44: 88–105 Year: 2009 The biology of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=61 Year: 2001 Clinical significance and functional roles of FoxM1 in non-small cell lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Tumor-related angiogenesis: role in tumour growth and metastasis formation Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Pulmonologists and lung cancer: pivotal role in multidisciplinary approach Source: Eur Respir J 2013; 42: 1183-1185 Year: 2013 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 The role of tumor size in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006 Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010 Therapeutic options targeting angiogenesis in nonsmall cell lung cancer Source: Eur Respir Rev 2014; 23: 79-91 Year: 2014 Interleukin-17 enhances the net angiogenic potential and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 Non-small cell lung cancer with single brain metastasis: the role of surgical treatment Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005